Recipharm has equipped three more of its facilities with serialization capabilities in line with the U.S. regulatory requirements and today’s introduction of the Drug Supply Chain Security Act (DSCSA).  The facilities in Brescia, Italy and Karlskoga and Uppsala, Sweden, have been equipped to supply serialized products to the U.S., bringing the total number of facilities offering serialization capabilities to nine. The company invested €40 million in a company-wide implementation program...